Scienture Holdings, Inc. SCNX
0.28
(0.01)
(3.45%)
as of 25 Sep
- Market cap
- $12.3M
- P/E
- 0.0×
Follow SCNX
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(24.50%) | (55.65%) | (56.56%) | (53.47%) | |
| (20.65%) | (43.92%) | (44.76%) | (39.53%) | ||
ROIC |
(13.06%) | (41.95%) | (42.01%) | (38.25%) | |
Return on Tangible Assets |
347.54% | (798.85%) | (2,108.02%) | (613.11%) | |
Average Days of Receivables |
299.81 | 550.59 | 540.39 | 171.23 | |
Free Cash Flow per Share |
(0.59) | (0.87) | (0.33) | (0.36) | |
Free Cash Flow |
(11.11) | (13.38) | (13.34) | (14.44) | |
Piotroski F-Score |
2.00 | 4.00 | 5.00 | 4.00 | |
| Other line items | |||||
Cash ROIC |
(13.30%) | (17.43%) | (18.96%) | (17.64%) | |
Accounts Receivable Turnover |
0.51 | 0.18 | 0.20 | 0.37 | |
Accounts Payable Turnover |
0.04 | 0.07 | 0.04 | 0.05 | |
Inventory Turnover |
1.16 | 1.37 | 0.94 | 0.96 | |
Average Days of Payables |
9,835.72 | 3,502.69 | 4,997.58 | 3,316.47 | |
Days of Inventory on Hand |
627.97 | 517.89 | 750.28 | 734.70 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
357.77% | 403.51% | 445.80% | 304.23% | |
Selling, General and Administrative Expense of Revenue |
1,452.03% | 2,071.89% | 1,944.14% | 799.48% | |
Share Based Compensation of Revenue |
861.87% | 1,315.80% | 1,106.74% | 321.53% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.54 | 0.32 | 0.32 | 0.38 | |
Depreciation/Fixed assets |
231.29 | 235.67 | 239.79 | 252.02 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
0.04 | 0.03 | 0.01 | 0.02 | |
Operating CF per Share |
(0.59) | (0.87) | (0.33) | (0.36) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(2,861.18%) | (8,562.77%) | (8,575.94%) | (4,621.02%) |
Columns are period end dates